|
|
|
|
| LEADER |
01950nam a2200325 u 4500 |
| 001 |
EB002000818 |
| 003 |
EBX01000000000000001163719 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
210907 r ||| eng |
| 245 |
0 |
0 |
|a Pharmacoeconomic review report: Tiotropium bromide monohydrate (Spiriva respimat) for inhalation
|h Elektronische Ressource
|
| 246 |
3 |
1 |
|a Tiotropium bromide monohydrate (Spiriva respimat) for inhalation
|
| 260 |
|
|
|a [Ottawa, Ontario]
|b Canadian Agency for Drugs and Technologies in Health
|c July 2015, 2015
|
| 300 |
|
|
|a 1 PDF file (ii, 9 pages)
|
| 505 |
0 |
|
|a Includes bibliographical references
|
| 653 |
|
|
|a Administration, Inhalation
|
| 653 |
|
|
|a Canada
|
| 653 |
|
|
|a Cost-Benefit Analysis
|
| 653 |
|
|
|a Tiotropium Bromide / economics
|
| 653 |
|
|
|a Muscarinic Antagonists / economics
|
| 653 |
|
|
|a Pulmonary Disease, Chronic Obstructive / drug therapy
|
| 653 |
|
|
|a Nebulizers and Vaporizers / economics
|
| 710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a CADTH common drug review
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK535472
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 082 |
0 |
|
|a 330
|
| 520 |
|
|
|a Tiotropium bromide Soft Mist Inhaler (Spiriva Respimat; Tio R 5) is a long-acting muscarinic antagonist (LAMA) indicated as a long-term, once-daily maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema, and for the reduction of exacerbations. The manufacturer is requesting a listing in line with the indication. Tio R 5 is available as a multi-use cartridge containing 60 2.5 mcg actuations. As the recommended dose of Tio R 5 is two inhalations of 2.5 mcg (5 mcg) once daily, each cartridge provides a 30-day supply
|